We are live on ! Find out more
AVNR

AVANIR PHARMACEUTICALS, INC CL A
AVNR

Delisted

AVNR was delisted on the 12th of January, 2015.

95 hedge funds and large institutions have $473M invested in AVANIR PHARMACEUTICALS, INC CL A in 2013 Q2 according to their latest regulatory filings, with 95 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more call options, than puts

Call options by funds: $5.99M | Put options by funds: $3.33M

Holders
95
Holders Change
+95
Holders Change %
% of All Funds
3.1%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
95
Increased
Reduced
Closed
Calls
$5.99M
Puts
$3.33M
Net Calls
+$2.67M
Net Calls Change
+$2.67M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

AVNR Hedge Fund Activity: Q2 2013 in Review

95 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q2 2013, worth a combined $473M.

Buyers outnumbered sellers: 95 funds opened new AVNR positions and 0 closed out — a net gain of 95 holders — while 0 added to existing stakes and 0 trimmed.

  • 95 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $473M of AVANIR PHARMACEUTICALS, INC CL A stock for Q2 2013.
  • 95 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q2 2013 and 0 closed out, a net change of +95 holders.

Based on aggregated 13F filings for Q2 2013.